Velcade Consolidation Bone Study

NCT01286077 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

106

Enrollment

INDUSTRY

Sponsor class

Conditions

Multiple Myeloma

Interventions

DRUG: bortezomib

Sponsor

Janssen-Cilag International NV